Clinical Study of BRL-101 in Severe SCD

Conditions: Sickle Cell Disease Interventions: Drug: Autologous hematopoietic stem and progenitor cells injection Sponsors: Bioray Laboratories; First Affiliated Hospital of Guangxi Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials